Weight Loss News and Research

Latest Weight Loss News and Research

Third-quarter fiscal 2009 results announced by Medifast

Medifast, Inc., a provider of leading clinically proven portion-controlled weight-loss programs, announced today third quarter financial results for the period ended September 30, 2009.

29 Oct 2009

Proper diet and exercise reduce risk of type 2 diabetes

Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent over 10 years in people at high risk for the disease.

29 Oct 2009

Aerobic exercise not only prevents weight gain, but also inhibits regain of harmful visceral fat

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

29 Oct 2009

Diabetes alerts for seniors from Always Best Care Senior Services

November is National Diabetes Month. And, Michael Newman, president of Always Best Care Senior Services, wants to alert seniors about the risks they face with this insidious disease.

28 Oct 2009

Treatment with TYSABRI reduces the rate of hospitalization in Crohn’s patients

Elan Corporation, plc and Biogen Idec today announced data showing that treatment with TYSABRI® (natalizumab) significantly reduced the rate of hospitalization compared with placebo in patients with moderate–to–severe Crohn’s disease during both induction and maintenance treatment.

28 Oct 2009

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

Orexigen® Therapeutics, Inc. today announced results from new intent to treat (ITT) analyses from the COR-I and COR-II Phase 3 trials of Contrave® (naltrexone SR/bupropion SR), the first of two late stage Orexigen candidates for the treatment of obesity. These data expand on top-line results announced in July and complement findings from a panel discussion on Saturday where the Company presented data on Contrave patients who completed 56 weeks of therapy.

28 Oct 2009

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.

28 Oct 2009

Mirafit fbcx reduces human body absorption of consumed fat

A scientific study to be presented today at the annual meeting of The Obesity Society will confirm significant weight loss using the pill mirafit fbcx®. Dr. K-L Catherine Jen and Dr. Joseph Artiss, principals at ArtJen Complexus USA, LLC, will present these clinical study findings today, October 27, at The Obesity Society 2009 annual scientific meeting at the Marriott Wardman Park Hotel in Washington, D.C., The Obesity Society's 27th annual scientific meeting.

28 Oct 2009

GI Dynamics’ EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment demonstrates safety

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced data which support the safety and efficacy of the EndoBarrier™ Gastrointestinal Liner for pre-surgical weight loss treatment, along with a positive effect on glucose homeostasis in morbidly obese patients with type 2 diabetes mellitus.

27 Oct 2009

Hope for lung cancer patients

Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year. It is also estimated that lung cancer will cause 159,000 deaths in the United States this year - more than the total number of deaths resulting from breast, colon and prostate cancers combined.

27 Oct 2009

Want to shed more weight? Enroll a family member or friend

Enrolling in a weight loss program with a family member or friend appears to enhance weight loss among African Americans, but only if the involved partner attends sessions frequently or also loses weight, according to a report in the October 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Oct 2009

Detecting the cause of occult gastrointestinal bleeding with the PillCam SB video capsule demonstrated

Given Imaging Ltd. today announced that new data presented at the American College of Gastroenterology (ACG) 2009 Conference show that by visualizing the small bowel with the PillCam® SB video capsule, physicians can detect the cause of occult gastrointestinal bleeding (OGIB) and adapt how they manage and treat these patients.

27 Oct 2009

New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI

Solvay Pharmaceuticals, Inc. announced that new data demonstrate that CREON®( )(pancrelipase) Delayed-Release Capsules significantly improves a key measure of fat absorption in adults with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP) or pancreatic surgery.

27 Oct 2009

Cardio Infrared Technologies to deliver new Cardio-Cor II unit to Utah and Florida

Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.

27 Oct 2009

DVD series "Start Fitness Now: Beating Type 2 Diabetes" released

NBC's "Biggest Loser" trainer Kim Lyons announces the newest addition to her fitness empire- 3 title DVD series Start Fitness Now: Beating Type 2 Diabetes and online support forum; produced and distributed by Watch It Now Entertainment.

26 Oct 2009

AlterG M300 anti-gravity treadmill for physical therapy clinics, fitness and training facilities

AlterG, Inc., makers of the Anti-Gravity Treadmill, a revolutionary technology for rehabilitation and athletic training, today launched the AlterG M300. The M300 delivers the same anti-gravity technology originally developed at NASA and found in AlterG's P200 series, only at a third of the price and with a sleek new design.

26 Oct 2009

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.

26 Oct 2009

Smart for Life Cookie Diet program helps people to keep weight off

Brooke Webb Masten, featured in Smart for Life broadcast advertising, has maintained her 105-pound weight loss and reached her 3-year milestone. She continues her success by eating Smart for Life cookies, shakes, soups and muffins as well as an exercise routine.

24 Oct 2009

Nutripure Beverages to expand its distribution network

NutriPure Beverages, Inc. and its subsidiary XND Technologies, Inc. announced today that they are in final negotiations with a Southern California-based distributor located in Santa Ana.

24 Oct 2009

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar® (sorafenib) tablets for the treatment of patients with radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer.

23 Oct 2009

Weight Loss News and Research

Latest Weight Loss News and Research

Third-quarter fiscal 2009 results announced by Medifast

Proper diet and exercise reduce risk of type 2 diabetes

Aerobic exercise not only prevents weight gain, but also inhibits regain of harmful visceral fat

Diabetes alerts for seniors from Always Best Care Senior Services

Treatment with TYSABRI reduces the rate of hospitalization in Crohn’s patients

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

Mirafit fbcx reduces human body absorption of consumed fat

GI Dynamics’ EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment demonstrates safety

Hope for lung cancer patients

Want to shed more weight? Enroll a family member or friend

Detecting the cause of occult gastrointestinal bleeding with the PillCam SB video capsule demonstrated

New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI

Cardio Infrared Technologies to deliver new Cardio-Cor II unit to Utah and Florida

DVD series "Start Fitness Now: Beating Type 2 Diabetes" released

AlterG M300 anti-gravity treadmill for physical therapy clinics, fitness and training facilities

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Smart for Life Cookie Diet program helps people to keep weight off

Nutripure Beverages to expand its distribution network

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Weight Loss News and Research

Latest Weight Loss News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in